NF-κB activation in premalignant mouse tal-1/scl thymocytes and tumors

Blood

Volumn 102, Issue 7, 2003, Pages 2593-2596

  O'Neil, Jennifer ^b   Ventura, Juan Jose ^b   Cusson, Nicole ^b   Kelliher, Michelle ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; P65 PROTEIN; PROTEIN; PROTEIN P50; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD8 ANTIGEN; DNA BINDING PROTEIN; I KAPPA B; ONCOPROTEIN; TAL1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; BCL 2 GENE; CELL MATURATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; GENE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; I KAPPA B ALPHA GENE; LEUKEMOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE; PRECANCER; PRIORITY JOURNAL; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA; T CELL LYMPHOMA; TAL 1 SCL GENE; THYMOCYTE; TRANSGENIC MOUSE; TUMOR GROWTH; ACUTE LYMPHOCYTIC LEUKEMIA; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; T LYMPHOCYTE; THYMOMA; THYMUS;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; I-KAPPA B PROTEINS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; T-LYMPHOCYTES; THYMUS GLAND; THYMUS NEOPLASMS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 0141481979     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0090     Document Type: Article

References (13)

1. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999;18:6938-6947.
2. Karin M, CaoY, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301-310.
3. Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia. 2000;14:399-402.
4. Begley CG, Green AR. The SCL gene: from case report to critical hematopoietic regulator. Blood. 1999;93:2760-2770.
5. Kelliher MA, Seldin DC, Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 1996;15:5160-5166.
6. O'Neil J, Billa M, Oikemus S, Kelliher M. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice. Oncogene. 2001;20:3897-3905.
7. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75-87.
8. Mudgett JS, Ding J, Guh-Siesel L, et al. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A. 2000;97:10454-10459.
9. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 1999;13:382-387.
10. Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 1999;13:400-411.
11. Chen C, Edelstein LC, Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol. 2000;20:2687-2695.
12. Voll RE, Jimi E, Phillips RJ, et al. NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity. 2000;13:677-689.
13. Kim D, Xu M, Nie L, et al. Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NFκB activities. Immunity. 2002;16:9-21.